PT-141 for sexual dysfunction: what TikTok gets wrong about bremelanotide

What did @kkelly1865 actually say?

She described turning bright red after taking what the video context identifies as PT-141 (bremelanotide), calling herself "beet red" and comparing the color to a sunburn. She noted it typically fades in "about 45 minutes" and seemed surprised by the intensity this time. That is the entire medical claim in this video, and it is actually a well-documented side effect worth unpacking.

To be clear, there is no dosing information here, no condition being treated explicitly, and no instructions being given. What we have is a firsthand account of a vasodilatory flush response. The question is whether her description lines up with what the pharmacology actually predicts, and largely, it does. The "biracial tomato" joke does not change that the physiology she is describing is real.

Does the science back this up?

Yes, flushing is one of the most consistently reported side effects of PT-141, and the mechanism is well understood. PT-141 is a melanocortin receptor agonist, primarily targeting MC1R, MC3R, and MC4R. Activation of peripheral melanocortin receptors triggers vasodilation, which is what produces the visible redness and warmth.

In the Phase III clinical trial data that led to FDA approval of bremelanotide (Vyleesi) in 2019, flushing was reported in approximately 40% of participants (Simon et al., 2019, Obstetrics and Gynecology). It was the single most common adverse event. The onset is typically rapid, occurring within 30 to 60 minutes of administration, and resolution usually happens within one to two hours. Her "45 minutes" estimate is consistent with this window, though individual variation is significant depending on dose, route, and body composition.

What is less clear from the video is whether she is using pharmaceutical-grade bremelanotide or a compounded research-grade version. That distinction matters for predicting both intensity and duration of side effects, and no equivalency should be assumed between those two forms.

What did they get wrong (or right)?

She got the core observation right. Flushing from PT-141 is real, common, and self-limiting. Her description of it fading in about 45 minutes also falls within the documented range. Give credit where it is due.

What she did not address, and what the laughing-emoji framing possibly obscures, is that flushing from melanocortin agonists is not always benign. In the Vyleesi clinical program, nausea accompanied flushing in a significant subset of users, and transient increases in blood pressure were also observed (Clayton et al., 2018, Journal of Sexual Medicine). The FDA label for bremelanotide specifically warns against use in people with cardiovascular disease for this reason.

Presenting a bright-red face as a punchline without any of that context is not misinformation exactly, but it leaves viewers who might be considering this peptide without information they actually need. The "it never got me this red before" line is also worth flagging: variable response intensity across uses can reflect dose changes, compounding batch differences, or changes in individual tolerance, none of which should be dismissed as quirky.

What should you actually know?

If you are seeing flushing this intense, a few things are worth understanding. First, facial flushing from PT-141 is a pharmacological effect of melanocortin receptor activation, not an allergic reaction in most cases. But you cannot self-diagnose that distinction. A true hypersensitivity reaction can also cause redness and warmth, and distinguishing between the two without clinical oversight is not something a TikTok comment section can help you with.

Second, the intensity of flushing does not necessarily correlate with efficacy. More red does not mean the peptide is working better. Third, bremelanotide has an FDA-approved form (Vyleesi) for hypoactive sexual desire disorder in premenopausal women. Compounded versions circulating in the peptide community are not the same product and carry their own set of quality and safety uncertainties.

If you are experiencing cardiovascular symptoms alongside flushing, including chest tightness, palpitations, or significant blood pressure changes, that is not a "45 minutes and it goes away" situation. That requires actual medical evaluation. Anyone using PT-141 outside of a supervised clinical context is taking on risks that a short TikTok video does not come close to covering.